Stock listing

A2H8SU Stock Price, News, Filings & Events — Advicenne Sa

Selected listing: A2H8SU · LS · EUR · DE

The A2H8SU:LS listing represents Advicenne Sa, a biopharmaceutical company focused on developing innovative treatments for rare kidney diseases. Recently, Advicenne has been active in advancing its clinical programs and engaging with regulatory authorities to facilitate the approval of its therapies. The company regularly updates its investors through filings and news releases, highlighting its progress and strategic initiatives in the market. As it navigates the complexities of the biopharmaceutical landscape, Advicenne continues to position itself as a key player in addressing unmet medical needs.

A2H8SU:LSEURDEUpdated July 21, 2026
Advicenne Sa logo
Ticker
A2H8SU:LS
Asset type
Stock
Market cap
$27.0M
Sector
Health Technology
Industry
Pharmaceuticals: Generic
Exchange
LS
Currency
EUR

Advicenne Sa A2H8SU:LS stock context

The A2H8SU:LS listing represents Advicenne Sa, a biopharmaceutical company focused on developing innovative treatments for rare kidney diseases. Recently, Advicenne has been active in advancing its clinical programs and engaging with regulatory authorities to facilitate the approval of its therapies. The company regularly updates its investors through filings and news releases, highlighting its progress and strategic initiatives in the market. As it navigates the complexities of the biopharmaceutical landscape, Advicenne continues to position itself as a key player in addressing unmet medical needs.

Research Advicenne Sa

Alternate listings